|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
���� |
|
ø�� |
|
���Ժ����� |
| ��������������� | |
|
������ |
|
��ѧ˼ |
| PubMed | |
|
Article by |
|
Article by |
���Ժ������ж���ø��������
������, ��ѧ˼
�й�ҽѧ��ѧԺ���й�Э��ҽ�ƴ�ѧƤ�����о���, �Ͼ�210042
����������Ⱦɫ���ĩ��,����ø��һ����RNA�͵�������ɵĺ��Ǻ˵���,��������RNAΪģ�岻�Ϻϳɶ���,��ϸ�����������������йء�����ø�ڶ��Ժ������ķ�����չ�����о�����Ҫ����,Ϊ���Ժ�������������ϡ����Ƽ�Ԥ���ṩ���µ�;����
[2] Pathak S, Multani AS, McConkey DJ, et al. Spontaneous regression of cutaneous melanoma in sinclair swine is associated with defective telomerase activity and extensive telomere erosion. Int J Oncol, 2000,17(6):1219-1224.
[3] Avilion AA, Piatyszek MA, Gupta J, et al. Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res, 1996, 56(3):645-650.
[4] Parris CN, Jezzard S, Silver A, et al. Telomerase activity in melanoma and non-melanoma skin cancer. Br J Cancer, 1999, 79(1):47-53.
[5] Dhaene K, Vancoillie G, Lambert J, et al. Absence of telomerase activity and telemorase catalytic subunit mRNA in melanocyte cultures.Br J Cancer, 2000, 82(5):1051-1057.
[6] Wynford-Thomas D. Cellular senescence and cancer. J Pathol, 1999,187(1):100-11.
[7] Kyo S, Kanaya T, Takakura M, et al. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues. Int J Cancer, 1999, 80(1):60-63.
[8] Villa R, Porta CD, Folini M, et al. Possible regulation of telomerase activity by transcription and alternative splicing of telomerase reverse transcriptase in human melanoma. J Invest Dermatol, 2001, 116 (6):867-873.
[9] Ayyoub M, Migliaccio M, Guillaume P, et al. Lack of tumor recognition by hTERT peptide 540-548-specific CD8 (+) T cells from melanoma patients reveals inefficient antigen processing. Eur J Immunol, 2001,31 (9):2642-2651.
[10] Ramirez RD, DAtri S, Pagani E, et al. Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma. Neoplasia, 1999, 1 (1):42-49.
[11] Kyo S, Kanaya T, Takakura M, et al. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors. Int J Cancer, 1999, 80(6):804-809.
[12] Miracco C, Pacenti L, Santopietro R,et al. Evaluation of telomerase activity in cutaneous melanocytic proliferations. Hum Pathol, 2000,31 (9):1018-1021.
[13] Rudolph P, Schubert C, Tamm S, et al. Telomerase activity in melanocytic lesions:A potential marker of tumor biology. Am J Pathol,2000, 156(4):1425-1432.
[14] Glaessl A, Bosserhoff AK, Buettner R,et al. Increase in telomerase activity during progression of melanocytic cells from melanocytic naevi to malignant melanomas. Arch Dermatol Res, 1999, 291 (2-3):81-87.
[15] McEachern MJ, Blackburn EH. Runaway telomere elongation caused by telomerase RNA gene mutations. Nature, 1995, 376 (6539):403-409.
[16] Miracco C, De Santi MM, Lalinga AV, et al. Lipomatous mixed tumour of the skin:a histological, immunohistochemical and ultrastructural study. Br J Dermatol, 2002, 146(5):899-903.